Alan Black - Equilibar

Alan Black

Applications Engineer

hydrodynamic simulation, type la supernova remnant

As Applications Engineer for Equilibar, Alan Black is the first person most clients communicate with about their pressure control needs. He is able to assess technical details and make timely and accurate quotations. He works creatively with other engineers and researchers to find the best possible solution for difficult and complex problems.

Alan has a B.S. Degree in Physics from North Carolina State University where he did undergraduate research in computational astrophysics. His main focus was hydrodynamic simulations of supernova remnants, a skill he continues to use as he models the performance of valves and regulators. The image at left is a hydrodynamic simulation of a type Ia supernova remnant at an age of 100 seconds, colored by density. Below are an X-ray image of the G19 remnant and a simulation of an idealized remnant with a perfectly spherically symmetric density profile.

Before joining Equilibar, Alan spent a year with Virginia Tech’s graduate program and worked as a tutor for physics and math.

“I enjoy solving complicated problems for clients and using computational modeling to size and predict the performance of valves,” he says. “I like seeing how our technology can be used in unusual ways.”

Alan also develops custom electronic controls and software for integration with Equilibar products. His areas of interest include aerospace applications, supercritical CO2 control, and cryogenic control.

Equilibar News
cover of PI magazine

Process Instrumentation cover story: Ryan Heffner discusses pharmaceutical fluid control

The November issue of Process Instrumentation magazine features a cover article by Ryan Heffner, single use technology manager for Equilibar, that provides a comprehensive overview of fluid control options for the fast-changing pharmaceutical industry. Researchers responding to the COVID epidemic dramatically accelerated the rate of change in the pharmaceutical industry as they developed vaccines and Read More

Read More